Study | Findings |
---|---|
Artac et al., 2013 [20] | Year 1 (high-risk only) Female vs. male (baseline): AOR = 0.80, 95% CI = 0.67–0.94 p < .010 Year 2 (all eligible patients) Female vs. male (baseline): AOR = 1.27, 95% CI = 1.20–1.35, p < .010 |
Attwood et al., 2016 [19] | Unadjusted model Female vs. male (baseline): OR = 1.50, 95% CI = 1.16–1.95, p < .050 Model adjusted for GP surgery effects Female vs. male (baseline): AOR = 1.29, 95% CI = 0.95–1.76, p > .050 |
Cochrane et al., 2013 [23] | Female vs. male (baseline): OR = 0.70, 95% CI = 0.58–0.84, p < .001 |
Coghill et al., 2018 [22] | Male vs. female (baseline): AOR = 0.73, 95% CI = 0.67–0.80, p < .001 |
Cook et al., 2016 [26] | Female uptake rate = 50%; male uptake rate = 38%, p < .001 |
Dalton et al., 2011 [24] | Significant age x gender interaction; women in the youngest age-group (35–54 years) more likely to attend than men in the same age category: AOR = 1.71, 95% CI = 1.03–2.85, p = .037 |
Gidlow et al., 2014 [9] | Female vs. male (baseline): OR = 1.47, 95% CI = 1.30–1.68, p < .001 |
McDermott et al., 2018 [25] | Male vs. female (baseline): AOR = 0.74, 95% CI = 0.69–0.80, p < .001 |
Sallis et al., 2016 [21] | Female vs. male (baseline): AOR = 1.50, 95% CI = 1.29–1.74, p < .010) |